We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Imperial Brands Plc | IMB | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 25.00 | 0.93% | 2,721.00 | 16:35:26 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2,700.00 | 2,689.00 | 2,717.00 | 2,721.00 | 2,696.00 |
| Industry Sector |
|---|
| TOBACCO |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 08/10/2024 | Interim | GBP | 0.4008 | 30/09/2025 | 30/09/2025 | |
| 08/10/2024 | Interim | GBP | 0.4008 | 21/08/2025 | 22/08/2025 | 30/09/2025 |
| 08/10/2024 | Interim | GBP | 0.4008 | 30/06/2025 | 30/06/2025 | |
| 08/10/2024 | Interim | GBP | 0.4008 | 22/05/2025 | 23/05/2025 | 30/06/2025 |
| 15/05/2024 | Final | GBP | 0.5426 | 20/02/2025 | 21/02/2025 | 31/03/2025 |
| 15/05/2024 | Interim | GBP | 0.5426 | 28/11/2024 | 29/11/2024 | 31/12/2024 |
| 15/05/2024 | Interim | GBP | 0.2245 | 22/08/2024 | 23/08/2024 | 30/09/2024 |
| 15/05/2024 | Interim | GBP | 0.2245 | 23/05/2024 | 24/05/2024 | 28/06/2024 |
| 14/11/2023 | Final | GBP | 0.5182 | 15/02/2024 | 16/02/2024 | 28/03/2024 |
| 14/11/2023 | Interim | GBP | 0.5182 | 23/11/2023 | 24/11/2023 | 29/12/2023 |
| 16/05/2023 | Interim | GBP | 0.2159 | 17/08/2023 | 18/08/2023 | 29/09/2023 |
| 16/05/2023 | Interim | GBP | 0.2159 | 25/05/2023 | 26/05/2023 | 30/06/2023 |
| 15/11/2022 | Final | GBP | 0.4932 | 16/02/2023 | 17/02/2023 | 31/03/2023 |
| 15/11/2022 | Interim | GBP | 0.4931 | 24/11/2022 | 25/11/2022 | 30/12/2022 |
| 17/05/2022 | Interim | GBP | 0.2127 | 18/08/2022 | 19/08/2022 | 30/09/2022 |
| 17/05/2022 | Interim | GBP | 0.2127 | 26/05/2022 | 27/05/2022 | 30/06/2022 |
| 16/11/2021 | Final | GBP | 0.4848 | 17/02/2022 | 18/02/2022 | 31/03/2022 |
| 16/11/2021 | Interim | GBP | 0.4848 | 25/11/2021 | 26/11/2021 | 31/12/2021 |
| 18/05/2021 | Interim | GBP | 0.2106 | 19/08/2021 | 20/08/2021 | 30/09/2021 |
| 18/05/2021 | Interim | GBP | 0.2106 | 27/05/2021 | 28/05/2021 | 30/06/2021 |
| 17/11/2020 | Final | GBP | 0.4801 | 18/02/2021 | 19/02/2021 | 31/03/2021 |
| Interim | GBP | 0.48 | 26/11/2020 | 27/11/2020 | 31/12/2020 | |
| Interim | GBP | 0.48 | 26/11/2020 | 27/11/2020 | 31/12/2020 | |
| Interim | GBP | 0.2085 | 20/08/2020 | 21/08/2020 | 30/09/2020 | |
| Interim | GBP | 0.2085 | 28/05/2020 | 29/05/2020 | 30/06/2020 | |
| 08/07/2019 | Final | GBP | 0.7201 | 20/02/2020 | 21/02/2020 | 31/03/2020 |
| 05/11/2019 | Final | GBP | 0.7201 | 20/02/2020 | 21/02/2020 | 31/03/2020 |
| Top Posts |
|---|
Posted at 28/1/2025 16:44 by jrphoenixw2 I've just been skimming notifications from my broker. One I'd missed was that yesterday at the open IMB spiked to 2693p, reportedly a new 52wk high. |
Posted at 27/1/2025 11:49 by huckers marktime1231. Agree with all that. From my own perspective IMB is one of my biggest holdings. I've received a lot of dividends and am sitting on a > 75% capital gain. Being overweight this share I will trim no later than on the approach to 3,000p.Do you really think industry consolidation is on the cards? If so, IMB being one of the smaller players, would be a target... |
Posted at 27/1/2025 11:41 by marktime1231 Big tobacco being rewarded for backing Trump's election campaign. IMB sharing the benefit which will be felt more by those with a bigger presence in the US menthol market.I don't think you can put a ceiling on where IMB share price might reach while there is an ongoing aggressive buyback programme and the reliable prospect of enhanced dividends. Take some gains at a level you are happy with, but it would only make sense to sell out when there is the safe prospect of better long term income elsewhere. The question of what to do and when is likely to resolve itself with the next round of industry consolidation. I am minded to sit tight until then. |
Posted at 27/1/2025 08:20 by huckers That news well received by tobacco stocks. New multi-year high. I wonder where IMB will top out eventually... |
Posted at 31/12/2024 09:46 by laurence llewelyn binliner #Spud, I use Barclays SI, their dividend payments have to wait for their credit to come in before distribution to account holders, the USD dividends subject to an FX swap usually take a few days longer but they can all take up to 10 days, frustrating sometimes when you want to buy some stock, but it has panned out that waiting a few days brings better prices so swings and roundabouts..!Some brokers like II payout or at least credit their account holders on the button.. Good to see the DRIP here today adding some share price value.. :o) |
Posted at 22/11/2024 23:56 by garycook The IMB future Dividend yield is now currently 7.45% 188.68p/2532p.The next four quarterly dividends are 54.26p,54.26p,40.08, |
Posted at 22/11/2024 19:03 by xtrmntr Imperial Brands (IMB) chief executive Stefan Bomhard highlighted the 4.6 per cent increase in net revenue as "the strongest top-line growth the company has recorded in more than a decade".The maker of Davidoff and Gauloises recorded market share gains in four of its five priority markets (the only exception was the UK, where a 50-basis point drop was blamed on an "inflation-linked excise increase".As decent as this sounds, this is still a case of (well) managed decline, though. The top-line growth came as a result of a 7.8 per cent uplift in tobacco pricing, offsetting a 4 per cent drop in volumes. Imperial said this volume decline is showing signs of "normalising", after reporting a double-digit drop in the prior year following its exit from Russia.Management were encouraged by market share gains in Spain, Germany and the Americas, although the latter just meant the volume decline of 7.7 per cent it experienced was better than the market's slide of 9 per cent. It blamed cost-of-living pressures and "increased sales of illicit vaping products".Imperial's 'next-generation' products arm, which sells vapes, heated products and oral nicotine grew revenue by more than a quarter, boosting gross margins. However, although this allowed the division to cut its net loss by 43 per cent to £79mn, it remains a pretty small part of the overall operation (1 per cent of total revenue, or 4 per cent of net revenue, excluding duties).After increasing its dividend by 4.5 per cent and announcing it plans to buy back a further £1.25bn of shares this year, the company is set to return £2.8bn of capital, leaving it on track to deliver a cumulative £10bn to shareholders since it launched its current strategy in January 2021, Bomhard said. The next phase of its buyback strategy, covering the period until 2030, will be set out at a capital markets event in March.The 2 per cent share price gain post-results means Imperial's shares are up 36 per cent so far this year a racy gain for what is meant to be a slow-and-steady income share. In fact, as Panmure Liberum's Rae Maile points out, they have done better than three of the so-called 'Magnificent 7'.The difference, though, is that the Magnificent 7 operate in sectors that still offer some prospect of healthy growth. At 7-times forecast earnings and an implied dividend yield of 6.3 per cent, Imperial's shares look cheap, too. But given the lack of growth they're cheap for a reason. Hold. |
Posted at 09/10/2024 07:16 by muscletrade Proactive Investors - ESG advocates close your ears, but Imperial Brands PLC (LON:IMB) has proven once again that Big Tobacco stocks are some of the higher income generators on the market.Not only does the owner of Golden Virginia and Davidoff have an estimated 7% dividend yield, it is also on track to repurchase another 7% of its outstanding shares through newly announced buybacks. Rounding out a tidy 7-7-7, Panmure Liberum analysts noted that Imperial’s share price is currently trading at around seven times earnings. Analysts see this as “hugely undervalued”. Such is Imperial’s appetite for buybacks, that according to Panmure: “ Repurchases to date have retired 11.2% of the opening share count, or put another way, in two years Imperial has bought more shares than are owned by all but one of its institutional shareholders.” This shrinking equity base and progressive dividend policy is thanks to what Panmure Liberum analysts call “prodigious Although NGPs – being the array of vapes, heated products and pouches that Imperial sells – remains a loss-making segment, these losses continue to narrow while sales continue to enjoy double-digit growth. The wider group remains highly profitable regardless. “This is the result of continued strong pricing in cigarettes (once again belying the siren voices that cigarette pricing is ‘over),” said Panmure. All in all, “the company is doing everything right”, reckon Panmure analysts. Not that ESG advocates would agree. |
Posted at 09/10/2024 06:53 by xtrmntr Hargreaves: Imperial Brands lights up returns Imperial Brands (IMB) is driving growth in new products and 'legacy' tobacco, allowing it to 'up the ante' with shareholder returns, says Hargreaves Lansdown.The Citywire Elite Companies AAA-rated company delivered growth in next-generation products and tobacco revenues last year, in line with expectations. This allowed it to increase the full-year 2024 dividend by 4.5% to 153.43p it said dividends and buybacks will be increased £400m to £2.8bn next year, equal to a distribution yield of 15%.Analyst Derren Nathan said the group 'managed to drive growth not only in its fledgling next-generation brands, but also in "legacy" tobacco products which still make up the lion's share of the business'.Imperial Brands is expecting a 'significant acceleration' in next-generation products with revenue growth of 20%-30%.'Strong cash conversion is allowing it to up the ante on payouts to shareholders,' said Nathan, who added that next year's dividend target equates to about 176p per share but 'could end up being closer to 200p depending on the price which buybacks are effected at'.The shares gained 4.1% to £22.36 yesterday. |
Posted at 02/9/2024 22:51 by wunderbar I last posted on this bb on 22 Nov 2022 with the share price at 2185p. I was optimistic we might hit my breakeven/exit point 2400p within 3-6 months given positive momentum at the time. Instead, it turned out to be yet another false dawn. As it transpired, 2185p turned out to be the high point of 2022, thereafter the share price embarked on a 10 month steady decline losing 632p [-29%] bottoming out at 1554p in Oct 2023. Talk about a kick in the b0ll0x.During this period I added to my position to get my average down to 2280p. Today, almost 7 years after my initial purchase, I finally pulled the trigger and bailed out at 2193p. I mentioned in my last post I was determined to claw back my entire stake despite being comfortably in profit if I included dividend income over the years. However, I reluctantly accepted defeat and booked a capital loss of 3.9%. If I factor in dividend income [inc. capital loss] it works out my investment has generated an average yield of 4.76% per year. All in all IMB has been a poor investment for me. As I’ve previously mentioned, my cardinal sin was averaging down too frequently during 2018-2019, this gung-ho approach spectacularly backfired with the share price falling over 1000p during these two years. Who remembers the cries of “it can’t possibly go below 2500p” and “surely won’t go under 2000p”. We all know how that turned out. Some might ask why have I sold up when the share price is only c.90p from my break even point. Well, plenty reasons. First and foremost, IMB has been on a fantastic run since April, climbing 532p [YTD low: 1662p / high: 2194p]. I just can’t see this rise continuing indefinitely, in my opinion it’s starting to look toppy hence decision to sell. Also note IMB hit a five year high today [albeit by a narrow margin] of 2194p before falling back to close at 2183p. I’m very wary we’re back to a similar level seen two years ago when share price peaked at 2185p, then fell off a cliff. Right now it’s hard to tell if IMB’s share price is consolidating at this level before its next leg up, or if we’re now at a point where a correction is imminent. Obviously I’m banking on the latter. But if we do see c.2300p in coming weeks/months then so be it. You win some, you lose some. My priority here is two-fold; firstly, protect my capital, and secondly, reduce my exposure to tobacco sector noting I also hold BATS which I think has more upside potential, a superior dividend, and far greater NGP exposure [noting BATS NGP segment achieved a positive operating contribution in 2023, two years earlier than it originally estimated]. I’m also wary the FTSE is not far off its all-time high. At 8364 it looks bloated to me and I’m worried a sell-off would possibly wipe-out a large portion of IMB’s gains. I don’t want to chance hanging around for another sharp fall in share price I should add it was never my intention to build a significant stake in IMB [significant in relation to size of my portfolio]. This being a result of overzealous buying in 2018-2019. Too many eggs in one basket is never a good idea, something I learned the hard way during Covid crash in March 2020 when IMB tanked all the way down to 1200p. I'm also mindful of future government intervention, further tightening of regulations. In the US the FDA's planned ban on menthol cigarettes is still pending but I'd expect a decision in the next 12-18 months. This is more pertinent to British American Tobacco. Given the accelerated decline in cigarette volumes, particularly US/UK, I have real concerns IMB’s Next Generation Products are not growing fast enough to counter this fall. In May, IMB reported NGP revenues jumped 16.8%, nevertheless this category is still loss making. I fear it's going to take a very long time to accelerate NGP profits to a level comparable to cigarettes. I think NGP growth rate needs to be significantly higher otherwise this could become a major issue at some point. They can't keep plugging the gap with price increases. I came across a Sharecast article back in May titled “pressures are building for Imperial Brands, says Jefferies”. Below are some snippets. Jefferies has lifted its target price for Imperial Brands following a strong set of first-half results from the cigarette, tobacco and vape group last week, but has maintained a 'hold' rating, saying that pressures are building for the company. The broker hiked the target price for the shares from 1,710p to 1,850p. "IMB's 1H24 was very robust. We continue to feel it is over-earning, however, which could mean difficulties at some point," Jefferies said, highlighting two key areas of risk in combustibles and reduced risk products (RRP). In combustibles, the broker said the industry volume backdrop in Imperial's core markets "continues to get worse and we don't see things improving", with first-half volumes in Australia, the UK and US down 25.3%, 15.2% and 8.7% respectively. "The key metric to assess, for us, is its fair share of RRP relative to cigarettes. This is a minimum requirement, in our view. IMB are way away from this hurdle rate on our estimates, with estimated US and EU combustible share in FY23 at 15.0% vs RRP stick equivalent share at 1.4%," Jefferies said. Improving this, the broker said, will require a material uplift in spend. END To close off, I must admit it seems strange no longer having IMB in my portfolio. It was a tough decision to sell but I feel I can put the proceeds to better use elsewhere, specifically targeting companies with potential to make significant capital gains. At this moment in time my top choices are BP, IPO, PZC, CNA and ADIG [all of which I already hold]. But there are plenty more on my radar such as Reckitt Benckiser, Diageo and Burberry to name a few. Would I consider buying back into IMB? Absolutely. But definitely a much smaller stake, and only at a price point I feel offers value for money. For me that would be 1600-1750p. Until then! |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
